ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,550Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 45

$477K Total Retail Price of All Prescriptions

Rank: 19 out of 45

247 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

23% of this provider’s 247 patients filled at least one prescription for a schedule three drug, compared to an average of 25%.

Risky Drugs to Seniors

3% of this provider’s 7,626 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
SIMVASTATIN 530 409 1 4
METFORMIN HCL 453 381 2 8
AMLODIPINE BESYLATE 406 349 3 7
LISINOPRIL 381 284 4 2
INDAPAMIDE 357 299 5 132
LEVOTHYROXINE SODIUM 306 262 6 5
OMEPRAZOLE 304 236 7 3
ATORVASTATIN CALCIUM 266 225 8 12
HYDROCODONE-ACETAMINOPHEN 242 145 S3 9 1
BENAZEPRIL HCL 182 179 10 75
POTASSIUM CHLORIDE 157 139 11 13
CRESTOR 156 123 12 23
CARVEDILOL 156 127 12 25
FUROSEMIDE 154 141 14 6
LOSARTAN POTASSIUM 146 114 15 27
CITALOPRAM HBR 132 115 16 21
AMLODIPINE BESYLATE-BENAZEPRIL 131 97 17 77
ZETIA 125 104 18 50
GEMFIBROZIL 113 91 19 83
TRAMADOL HCL 105 69 20 20
ALLOPURINOL 104 90 21 36
MELOXICAM 102 93 22 28
DEXAMETHASONE 101 85 23 199
VITAMIN D2 99 62 24 202
METOPROLOL TARTRATE 91 88 25 10
METHYLPREDNISOLONE 84 65 26 86
DOXYCYCLINE HYCLATE 78 64 27 104
GLYBURIDE 78 49 R 27 55
GABAPENTIN 73 34 29 9
DOXAZOSIN MESYLATE 71 59 30 67
FINASTERIDE 70 56 31 142
ACTOS 66 57 32 115
PANTOPRAZOLE SODIUM 64 39 33 31
FLUCONAZOLE 63 57 34 133
WARFARIN SODIUM 62 59 35 17
AZITHROMYCIN 62 52 35 39
LANTUS 59 41 37 60
DIOVAN 58 58 38 43
ATENOLOL 58 47 38 15
MECLIZINE HCL 57 53 40 73
LOSARTAN-HYDROCHLOROTHIAZIDE 56 44 41 96
SPIRONOLACTONE 55 55 42 87
AMITRIPTYLINE HCL 55 31 R 42 42
ALPRAZOLAM 51 34 44 124
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.